Sort
15,273 grants matching “antimicrobial resistance”
Novel therapeutic agents from the bacterial symbionts of Brazilian invertebrates
$212,801David R Andes · Harvard Medical School · U19 · FY2017 · TW
Novel therapeutic agents from the bacterial symbionts of Brazilian invertebrates
$212,801David R Andes · Harvard Medical School · U19 · FY2016 · TW
Novel therapeutic agents from the bacterial symbionts of Brazilian invertebrates
$212,801David R Andes · Harvard Medical School · U19 · FY2018 · TW
Antibiotic Potentiation by Targeting of a Signal Transduction System
$212,782Robert S. Daum · University Of Chicago · R21 · FY2014 · AI
Novel Inhibitors of DNA Ligase LigA by Substrate-Assisted Tethered Inhibition
$212,722Peter J Tonge · State University New York Stony Brook · R21 · FY2016 · AI
Glutamine metabolism in tuberculosis
$212,704Lanbo Shi · Rbhs-New Jersey Medical School · R21 · FY2021 · AI
POLYMORPHISM/DIVERGENCE IN DROSOPHILA PATHOGEN DEFENSES
$212,702Cornell University Ithaca · R01 · FY2002 · AI
Harnessing Induced Human Intestinal Organoids (iHIOs) and Metagenomics to Unravel Host Immune-microbiota Interactions During Cancer Chemotherapy-associated Clostridium difficile Infections
$212,694Senu Apewokin · University Of Cincinnati · K08 · FY2023 · CA
Molecular Interactions of Toxin-Antitoxin Modules in P. aeruginosa (C. Bourne)
$212,682Christina R Bourne · University Of Oklahoma · P20 · FY2017 · GM
Nicotinamide-An Immune-Boosting Agent to Combat Antibiotic-Resistant Pathogens
$212,500George Y Liu · Cedars-Sinai Medical Center · R21 · FY2014 · AI
The Role of Enterococcus Unique Hypothetical EF1909 in Intrinsic β-lactam Resistance
$212,500Michael S. Gilmore · Massachusetts Eye And Ear Infirmary · R21 · FY2023 · AI
New understanding of LTA as a determinant of daptomycin susceptibility in VRE E. faecium
$212,500Michael S. Gilmore · Massachusetts Eye And Ear Infirmary · R21 · FY2020 · AI
Functional Role of the Enterococcal Polysaccharide Antigen
$212,388Konstantin V Korotkov · University Of Kentucky · R21 · FY2022 · AI
Optimization of a novel compound that enhances the activity of beta-lactams against Gram+ bacteria
$212,350Ambrose L. Cheung · Dartmouth College · R21 · FY2017 · AI
Localized gene expression within P. aeruginosa biofilms
$212,250Montana State University (Bozeman) · R21 · FY2005 · AI
MECHANISTIC CHARACTERIZATION OF A NOVEL ATTACHMENT PROTEIN IN PSEUDOMONAS AERUGINOSA
$212,250Yun Heacock-Kang · University Of Hawaii At Manoa · R21 · FY2019 · AI
INNATE HOST DEFENSE IN THE HUMAN VAGINA
$212,243University Of California Los Angeles · R01 · FY2002 · AI
Solid-state NMR studies of antimicrobial peptides
$212,190Mei Hong · Iowa State University · R01 · FY2007 · GM
Advancing Mentorship at the Johns Hopkins Integrated Center for Combating Antimicrobial Resistant Bacteria
$212,169Pranita Tamma · Johns Hopkins University · K24 · FY2025 · AI
Mechanisms underlying poor skin host defense in diabetic conditions
$212,080C. Henrique Serezani · Vanderbilt University Medical Center · R21 · FY2021 · AI
Novel Inhibitors of DNA Ligase LigA by Substrate-Assisted Tethered Inhibition
$212,062Peter J Tonge · State University New York Stony Brook · R21 · FY2015 · AI
Admin Core - Britton
$212,023Robert A Britton · Baylor College Of Medicine · U19 · FY2021 · AI
Development of Aminoglycoside-Nucleic Acid Conjugates for Inactivation of an Antibiotic Resistance-Conferring Aminoglycoside Sensing Riboswitch
$211,967Sandra Paige Story · Nubad, Llc · R43 · FY2016 · AI
INTERDISCIPLINARY PROGRAM IN BACTERIAL PATHOGENESIS
$211,952Ferric C Fang · University Of Washington · T32 · FY2016 · AI
Screening phage-host receptor interactions using thermal proteome profiling
$211,900Justin Michael Hutchison · University Of Kansas Lawrence · P20 · FY2022 · GM